Skip to content

Bachstim Registry: a Feasability Study of Bachmann's Area Pacing

BACHSTIM REGISTRY: a Feasability Prospective Study of Bachmann's Area Pacing

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07467031
Enrollment
200
Registered
2026-03-12
Start date
2026-04-01
Completion date
2028-04-01
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Conduction Disturbance

Brief summary

During pacemaker implantation, the atrial lead is commonly positioned in the right atrium. However, this pacing location can be problematic because it may disrupt physiological atrial activation, leading to atrial dyssynchrony. Such dyssynchrony has been associated with an increased risk of atrial fibrillation and its related complications. To mitigate atrial dyssynchrony, pacing of the Bachmann's bundle region has emerged as an alternative strategy. Bachmann's bundle is the principal interatrial conduction pathway, and pacing at this site may help preserve physiological atrial activation. Several studies have suggested that pacing in this region can significantly reduce the incidence of new-onset atrial fibrillation and heart failure in selected populations. To date, however, robust data from large cohorts regarding the feasibility of Bachmann's bundle area pacing and the factors associated with successful implantation remain limited. To address this gap, we established the Bachstim cohort study, aimed at determining the success rate of Bachmann's bundle area pacing and identifying the clinical and procedural factors associated with its feasibility.

Interventions

DEVICEBachmann's area pacing

In this study, the atrial lead will be targeted to the Bachmann's bundle area, rather than the conventional right atrial appendage pacing site.

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Cardiac pacemaker with atrial lead indication

Exclusion criteria

* patients \< 18 years old * pregnancy of breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Success of Bachmann's area pacing10 minutesSuccessful Bachmann's bundle area pacing is defined by a reduction of the paced P-wave duration by at least 30 ms when the spontaneous P-wave duration exceeds 120 ms, or by a reduction of the paced P-wave duration by at least 10 ms when the spontaneous P-wave duration is ≤120 ms.

Secondary

MeasureTime frame
Success of Bachmann's area pacing after 3 months follow-up3 months
Success of Bachmann's area pacing after12 months follow-up12 months
AF burden after 12 months follow-up12 months follow-up

Countries

France

Contacts

CONTACTJonaz FONT, MD, MSc
font-j@chu-caen.fr00332315118

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026